
YmAbs Announces Closing of $30 Million Extension of Private Equity Placement 29 November 2017
Common stock placement extended to a total of $80 million as Sofinnova Ventures and Scopia Capital Management... Read more

Common stock placement extended to a total of $80 million as Sofinnova Ventures and Scopia Capital Management... Read more

For knap to uger siden lykkedes det Orphazyme at gå på Børsen i København! Selskabet solgte 7,5 mio.... Read more

Orphazyme, a Danish biotech company with a late stage orphan drug pipeline, today published an offering... Read more

Det danske biotekselskab MonTa Biosciences har netop tegnet en licensaftale med UC San Diego Universitet... Read more

Orphazyme, a Danish biotech company with a late stage orphan drug pipeline, announces its intention to... Read more

Y-mAbs Therapeutics, Inc. closes $50 million in a private placement led by HBM Healthcare Investments... Read more

For nogle uger siden præsenterede regeringen sit erhvervs- og iværksætterudspil med 22 initiativer... Read more

Oral presentation of efficacy and safety data of Sym004 in refractory metastatic colorectal cancer Symphogen... Read more

Pan-Nordic mentor network NOME provides Nordic life science start-ups with the opportunity to present... Read more